{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "15494896",
  "DateCompleted": {
    "Year": "2005",
    "Month": "08",
    "Day": "18"
  },
  "DateRevised": {
    "Year": "2013",
    "Month": "11",
    "Day": "21"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1537-6591",
      "JournalIssue": {
        "Volume": "39 Suppl 5",
        "PubDate": {
          "Year": "2004",
          "Month": "Nov",
          "Day": "01"
        }
      },
      "Title": "Clinical infectious diseases : an official publication of the Infectious Diseases Society of America",
      "ISOAbbreviation": "Clin Infect Dis"
    },
    "ArticleTitle": "Resistance of herpes simplex virus infections to nucleoside analogues in HIV-infected patients.",
    "Pagination": {
      "StartPage": "S248",
      "EndPage": "S257",
      "MedlinePgn": "S248-57"
    },
    "Abstract": {
      "AbstractText": [
        "Antiviral treatment of herpes simplex virus (HSV) infections with nucleoside analogues has been well established for >2 decades, but isolation of drug-resistant HSV from immunocompetent patients has remained infrequent (0.1%-0.7% of isolates) during this period. Even when drug-resistant HSV is isolated from an immunocompetent patient, this virus, with rare exceptions, is cleared normally without adverse clinical outcome. Although drug-resistant HSV is more commonly isolated from immunocompromised patients (4%-7% of isolates) and is more likely to be clinically significant, the prevalence of drug-resistant HSV even among these patients, has been stable over the past 2 decades. Despite this stable prevalence, disease due to drug-resistant HSV remains an important problem for many immunocompromised patients, including those with HIV infection. This article reviews the prevalence, pathogenesis, and implications of drug-resistant HSV infections in HIV-infected patients."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Pediatric Infectious Diseases, University of Colorado Health Sciences Center, Denver, USA."
          }
        ],
        "LastName": "Levin",
        "ForeName": "Myron J",
        "Initials": "MJ"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Bacon",
        "ForeName": "Teresa H",
        "Initials": "TH"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Leary",
        "ForeName": "Jeffry J",
        "Initials": "JJ"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Clin Infect Dis",
    "NlmUniqueID": "9203213",
    "ISSNLinking": "1058-4838"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antiviral Agents"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Nucleosides"
    },
    {
      "RegistryNumber": "X4HES1O11F",
      "NameOfSubstance": "Acyclovir"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Acyclovir"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Animals"
    },
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Antiviral Agents"
    },
    {
      "QualifierName": [
        "genetics",
        "immunology"
      ],
      "DescriptorName": "Drug Resistance, Viral"
    },
    {
      "QualifierName": [
        "complications",
        "immunology"
      ],
      "DescriptorName": "HIV Infections"
    },
    {
      "QualifierName": [
        "complications",
        "drug therapy",
        "immunology"
      ],
      "DescriptorName": "Herpes Simplex"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunity, Cellular"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunocompetence"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunocompromised Host"
    },
    {
      "QualifierName": [
        "pharmacology",
        "therapeutic use"
      ],
      "DescriptorName": "Nucleosides"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Recurrence"
    },
    {
      "QualifierName": [
        "drug effects",
        "genetics",
        "pathogenicity"
      ],
      "DescriptorName": "Simplexvirus"
    }
  ],
  "NumberOfReferences": "94"
}